Pfizer and Amgen Among 22 Strategic Firms Expanding in Hong Kong
Global pharmaceutical giants Pfizer and Amgen are among 22 strategic enterprises planning to open or expand their offices in Hong Kong, according to sources cited by the South China Morning Post. This development marks the sixth cohort of companies under the Hong Kong government’s flagship investment-attraction initiative managed by the Office for Attracting Strategic Enterprises. The new batch of firms spans diverse high-growth sectors, including fintech, cloud computing, and aerial transport. Alongside Pfizer and Amgen, other notable companies such as Boehringer Ingelheim, Hengrui Medicine, HAYA, DiDi, and AutoFlight are expected to sign agreements to establish or enhance their presence in the region. Both Pfizer and Amgen hold significant market valuations, exceeding HK$1 trillion (US$153 billion) each as of April 2026. This influx underscores Hong Kong's ongoing efforts to reinforce its status as a global hub for healthcare, technology, and innovation. The expansion plans reflect confidence in the city's economic environment and regulatory framework, aiming to drive future growth in key strategic industries.
Wire timeline
Pfizer and Amgen Among 22 Strategic Firms Expanding in Hong Kong
Global pharmaceutical giants Pfizer and Amgen are among 22 strategic enterprises planning to open or expand their offices in Hong Kong, according to sources cited by the South China Morning Post. This development marks the sixth cohort of companies under the Hong Kong government’s flagship investment-attraction initiative managed by the Office for Attracting Strategic Enterprises. The new batch of firms spans diverse high-growth sectors, including fintech, cloud computing, and aerial transport. Alongside Pfizer and Amgen, other notable companies such as Boehringer Ingelheim, Hengrui Medicine, HAYA, DiDi, and AutoFlight are expected to sign agreements to establish or enhance their presence in the region. Both Pfizer and Amgen hold significant market valuations, exceeding HK$1 trillion (US$153 billion) each as of April 2026. This influx underscores Hong Kong's ongoing efforts to reinforce its status as a global hub for healthcare, technology, and innovation. The expansion plans reflect confidence in the city's economic environment and regulatory framework, aiming to drive future growth in key strategic industries.
News - South China Morning Post